Sarbani Chaudhuri

Vice President and Head, Hematology, GSCO
Johnson & Johnson Innovative Medicine

Sarbani is a biopharma executive leader who has built organizations and teams to deliver pioneering therapeutics that have radically transformed patient outcomes. Over her two-decade career, she has been at the forefront of driving enterprise growth and value creation, and shaping R&D strategies and licensing for disruptive innovation.

Currently, as the VP of Hematology, GCSO at J&J Innovative Medicine, her organization has driven multiple novel CAR-T and bispecific NMEs from development to launch and accelerated the next wave of novel therapies. In her prior role, as head of next gen ADC and Breast Cancer in AstraZeneca oncology business unit, she had steered exponential growth and a pioneering program to simultaneously unlock multiple tumors. Previously at Pfizer, she established oncology as the growth engine of the company with CDKi, and created the rare cardiac and neuromuscular franchise that transformed Pfizer to a rare disease category leader.

Sarbani has also championed innovation in digital health and next-gen diagnostics solutions and led multi-stakeholder collaborations to build sustainable health systems. She is passionate about leading and inspiring teams to redefine what is possible. Sarbani holds an MBA from The Wharton School and the Health Management program, and undergrad in engineering from University of Mumbai in India.